Dominik Koessinger

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

End Stage Renal Disease

Prognostic Factors

Top Venues

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Pierre Scheffler, Christian Fung, Shahan Momjian, Dominik Koessinger, Levin Häni, Nicolas Neidert, Jakob Straehle, Florian Volz, Oliver Schnell, Juergen Beck, Amir El Rahal
Dexamethasone in Patients with Glioblastoma: A Systematic Review and Meta-Analysis. Cancers 16 (7) (2024)
Pierre Scheffler, Christian Fung, Shahan Momjian, Dominik Koessinger, Levin Häni, Nicolas Neidert, Jakob Straehle, Florian Volz, Oliver Schnell, Juergen Beck, Amir El Rahal
Dexamethasone in Patients with Glioblastoma: A Systematic Review and Meta-Analysis. Cancers 16 (7) (2024)
Pierre Scheffler, Christian Fung, Shahan Momjian, Dominik Koessinger, Levin Häni, Nicolas Neidert, Jakob Straehle, Florian Volz, Oliver Schnell, Juergen Beck, Amir El Rahal
Dexamethasone in Patients with Glioblastoma: A Systematic Review and Meta-Analysis. Cancers 16 (7) (2024)
Anna L Koessinger, Catherine Cloix, Dominik Koessinger, Dieter Henrik Heiland, Florian J Bock, Karen Strathdee, Kevin Kinch, Laura Martínez-Escardó, Nikki R Paul, Colin Nixon, Gaurav Malviya, Mark R Jackson, Kirsteen J Campbell, Katrina Stevenson, Sandeep Davis, Yassmin Elmasry, Asma Ahmed, Jim O'Prey, Gabriel Ichim, Oliver Schnell, William Stewart, Karen Blyth, Kevin M Ryan, Anthony J Chalmers, James C Norman, Stephen W G Tait
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics. Cell death and differentiation 29 (10) (2022)